Sun Pharma presents Leqselvi data highlighting clinical efficacy, durability for Alopecia Areata treatment at 2024 Fall Clinical Dermatology Conference Ruchika Sharma28 Oct 2024 11:30 AM ISTMumbai: Sun Pharmaceutical Industries Limited has presented new data highlighting the clinical efficacy and safety of LEQSELVI (deuruxolitinib) 8...
Roche seeks to block Novo Nordisk's Catalent deal over weight-loss drug competition MD Bureau24 Oct 2024 2:09 PM IST"Limiting the competition in this space is not a good idea," Thomas Schinecker, CEO, Roche said.
Abbott's review plea challenging NPPA ceiling price fixation of 18 formulations rejected by DoP Farhat Nasim16 Oct 2024 4:59 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has dismissed two review applications filed by Abbott Healthcare Private Limited (AHPL) challenging...
Indian Pharma Market Grows 5.3% in September, Sun Pharma, Cipla take the lead: Pharmarack report Farhat Nasim14 Oct 2024 5:45 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) witnessed a growth of 5.3% in September 2024, primarily driven by the robust performance of key...
Rs 9.81 crore expenditure on Conference fees, accommodation to doctors, Business Promotion done by Sun Pharma disallowed:Â ITÂ Tribunal Farhat Nasim13 Oct 2024 12:15 PM ISTAhmedabad: The Income Tax Appellate Tribunal (ITAT) in Ahmedabad has upheld the disallowance of more than Rs 9.81 crore incurred by Sun Pharma...
Indian branded pharma Sector sees a decline in growth: Report Farhat Nasim9 Oct 2024 6:54 PM ISTCompanies such as Dr Reddys Laboratories (DRRD), Zydus Lifesciences (ZYDUSLIF), Lupin (LPC), and Mankind Pharma (MANKIND) expected to outperform on a...
Sun's RACIRAFT Vs JB Pharma's RANRAFT: Delhi HC gives interim trademark protection to Sun Pharma Farhat Nasim7 Oct 2024 6:07 PM ISTNew Delhi: In a respite to drug major Sun Pharmaceutical Industries Ltd, the Delhi High Court has granted an interim injunction restraining JB...
Sun Pharmaceutical Industry gets CDSCO Panel nod to study Aflibercept Injection Dr. Divya Colin6 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
Sun Pharma gets exclusive worldwide rights to commercialize Philogen anti-cancer immunotherapy Fibromun Ruchika Sharma1 Oct 2024 2:17 PM ISTMumbai: Sun Pharmaceutical Industries Limited and Philogen S.p.A have announced that they have entered into a global licensing agreement for...
Drugs in CDSCO samples Counterfeit, not ours, say leading pharma companies Ruchika Sharma28 Sept 2024 3:33 PM ISTNew Delhi: After a series of media articles announcing the results of the Monthly CDSCO drug alert report and pointing how major pharma samples...
Sun Pharma presents new clinical efficacy, safety data in severe dermatological conditions at 2024 EADV Congress Ruchika Sharma27 Sept 2024 3:51 PM ISTMumbai: Sun Pharmaceutical Industries Limited has announced that it will present abstracts across its dermatology portfolio at the 33rd European...
5 formulations declared as spurious including Sun Pharma's Ursocol 300, Glenmark's Telma H Dr. Divya Colin26 Sept 2024 6:00 PM ISTNew Delhi: In the latest spurious drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has declared 5...
